Technology

W. L. Gore & Associates Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Gore Viabahn Endoprosthesis for interventional treatment of in-stent restenosis in the superficial femoral artery (SFA).

Home October 03, 2014
Home
News

The Centers for Medicare & Medicaid Services (CMS) has determined that clinical sites that wish to participate in the newly announced CREST-2 carotid artery stenting (CAS) registry must receive accreditation.

Home October 03, 2014
Home
LotusValve
Feature

Boston Scientific Corp. has initiated the REPRISE III clinical trial, a pivotal study to evaluate the safety and effectiveness of the Lotus valve system in patients with severe aortic stenosis and who are considered to be at either high or extreme risk for surgical valve replacement.

Home October 02, 2014
Home
Claret Medical, Sentinel
Feature | Dave Fornell

While transcatheter aortic valve replacement (TAVR) is a paradigm shift in how valve disease is treated, one nagging safety issue that remains is TAVR’s stroke rate, which is higher than traditional surgical valve replacements. The solution to this issue may be the use of specialized embolic protection systems, of which four companies displayed their devices on the show floor and in presentations at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in September.

Home October 02, 2014
Home
News

Singulex Inc. announced the presentation of 10 abstracts at the European Society of Cardiology's (ESC) annual conference, which highlight the clinical utility of single molecule counting technology in the detection and quantification of biomarkers for cardiac disease, its comorbidities, and its risk factors.

Home October 02, 2014
Home
News

ReFlow Medical Inc. announced the initial clinical use of its Wingman35 Crossing Catheter and speX Shapeable Support Catheter by Dr. Andrej Schmidt at University Leipzig, Germany.

Home October 02, 2014
Home
News

October 1, 2014 — Heart Hospital of Austin is the first facility in Texas to implant a new miniaturized, wireless monitoring sensor to manage heart failure (HF). The CardioMEMS HF system is the first and only U.S. Food and Drug Administration (FDA) -approved HF monitoring device that has been proven to significantly reduce hospital admissions when used by physicians to manage HF.

Home October 01, 2014
Home
News

October 1, 2014 — St. Johns Hospital and Medical Center in Detroit recently became the first U.S. healthcare facility to install the Artis one angiography system from Siemens Healthcare. The Artis one is designed to address a broad range of angiographic procedures, from diagnosing and treating coronary artery disease and peripheral vessel occlusions to performing electrophysiology procedures.

Home October 01, 2014
Home
News

Although most accountable care organizations have the health information technology to improve clinical quality, poor interoperability across systems and providers remains a barrier, according to an ACO survey conducted by Premier Inc. and the eHealth Initiative.

Home October 01, 2014
Home
News

September 30, 2014 — The American College of Cardiology (ACC), along with eight partnering societies, released the first appropriate use criteria (AUC) for suspected heart disease in pediatric patients.

Home September 30, 2014
Home
Technology

September 30, 2014 — Acist Medical Systems Inc. showcased the HDi high-definition intravascular ultrasound system (HD-IVUS) in two live cases at the recent 2014 Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C.

Home September 30, 2014
Home
iFR
Feature | Jasvindar Singh, M.D., Washington University School of Medicine

Earlier this year, the Barnes-Jewish Hospital at Washington University School of Medicine in St. Louis adopted the instant wave-Free Ratio (iFR) technology. The iFR modality is a pressure-derived hyperemia-free index for assessment of coronary stenosis relevance.

Home September 30, 2014
Home
News

The U.S. Food and Drug Administration has allowed marketing of the NephroCheck test, a first-of-a-kind laboratory test to help determine if certain critically ill hospitalized patients are at risk of developing moderate to severe acute kidney injury (AKI) in the 12 hours following the administration of the test.

Home September 30, 2014
Home
News

Coquí RadioPharmaceuticals Corp. is working to become the first commercial producer of lifesaving medical isotopes in the United States.

Home September 30, 2014
Home
patient and doctor_iStock_2585809Large_0
Feature

September 29, 2014 — Before undergoing cardiac imaging procedures involving radiation, healthcare providers should help patients understand why the procedure is needed and its potential benefits and risks, including risks related to radiation exposure, according to a new scientific statement in the American Heart Association's (AHA) journal Circulation.

Home September 29, 2014
Home
Subscribe Now